Comparison of MicroRNA Levels of 18−60-month-old Autistic Children with Those of Their Siblings and Controls
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective: The present study aims to compare the levels of 7 microRNAs (mi-RNAs) (mi-RNA-125b, mi-RNA-23a-3p, mi-RNA-146a-5p, mi-RNA-106a, mi-RNA-151a-3p, mi-RNA-28, mi-RNA-125a) in the blood of the preschool children with autism and those of their siblings with healthy controls, and to investigate the association between these mi-RNAs and the severity of autism, behavioral problems, and siblings’ autistic traits. Methods: A total of 35 children diagnosed with autism spectrum disorder (ASD) at the ages of 18−60 months (patient group), 35 non-affected siblings of the ASD group (sibling group), and 30 control subjects (control group) were involved in the study. The severity of ASD was measured using the Childhood Autism Rating Scale and the Autism Behavior Checklist (ABC). The behavioral problems of the children with ASD were assessed with the Aberrant Behavior Checklist, and the autistic traits of the siblings were assessed using the Autism spectrum screening scale for children. Results: mi-RNA-106a-5p, mi-RNA-151a-3p, and mi-RNA-28-3p were found to be expressed significantly lower in the patient group compared to the control group. There was a significant positive correlation between mi-RNA-23a and the sensory subscale of the ABC. mi-RNA-151a was significantly associated with sound sensitivity and mi-RNA-28 with echolalia. After controlling for age and sex, the differences between groups were disappeared. Conclusion: The present study examined mi-RNAs that have been reported as biomarkers in the literature. Although several symptom clusters are found to be related to certain mi-RNA expression levels, they were not found to be significant in discriminating the patient and healthy groups.
Abstract
Objective: The present study aims to compare the levels of 7 microRNAs (mi-RNAs) (mi-RNA-125b, mi-RNA-23a-3p, mi-RNA-146a-5p, mi-RNA-106a, mi-RNA-151a-3p, mi-RNA-28, mi-RNA-125a) in the blood of the preschool children with autism and those of their siblings with healthy controls, and to investigate the association between these mi-RNAs and the severity of autism, behavioral problems, and siblings’ autistic traits. Methods: A total of 35 children diagnosed with autism spectrum disorder (ASD) at the ages of 18−60 months (patient group), 35 non-affected siblings of the ASD group (sibling group), and 30 control subjects (control group) were involved in the study. The severity of ASD was measured using the Childhood Autism Rating Scale and the Autism Behavior Checklist (ABC). The behavioral problems of the children with ASD were assessed with the Aberrant Behavior Checklist, and the autistic traits of the siblings were assessed using the Autism spectrum screening scale for children. Results: mi-RNA-106a-5p, mi-RNA-151a-3p, and mi-RNA-28-3p were found to be expressed significantly lower in the patient group compared to the control group. There was a significant positive correlation between mi-RNA-23a and the sensory subscale of the ABC. mi-RNA-151a was significantly associated with sound sensitivity and mi-RNA-28 with echolalia. After controlling for age and sex, the differences between groups were disappeared. Conclusion: The present study examined mi-RNAs that have been reported as biomarkers in the literature. Although several symptom clusters are found to be related to certain mi-RNA expression levels, they were not found to be significant in discriminating the patient and healthy groups.
참고문헌 (49)
- Tonacci A, "MicroRNA cross-involvement in autism spectrum disorders and atopic dermatitis : a literature review", J Clin Med, 8, pp.88~ (2019)
- Bailey A, "Autism as a strongly genetic disorder : evidence from a British twin study", Psychol Med, 25, pp.63~77 (1995)
- Pickles A, "Latent-class analysis of recurrence risks for complex phenotypes with selection and measurement error : a twin and family history study of autism", Am J Hum Genet, 57, pp.717~726 (1995)
- Gaugler T, "Most genetic risk for autism resides with common variation", Nat Genet, 46, pp.881~885 (2014)
- Bohm HV, "On the autistic spectrum disorder concordance rates of twins and non-twin siblings", Med Hypotheses, 81, pp.789~791 (2013)
- Issler O, "Determining the role of microRNAs in psychiatric disorders", Nat Rev Neurosci, 16, pp.201~212 (2015)
- Masi A, "An overview of autism spectrum disorder, heterogeneity and treatment options", Neurosci Bull, 33, pp.183~193 (2017)
- Geaghan M, "MicroRNA and posttranscriptional dysregulation in psychiatry", Biol Psychiatry, 78, pp.231~239 (2015)
- Hicks SD, "A comparative review of microRNA expression patterns in autism spectrum disorder", Front Psychiatry, 7, pp.176~ (2016)
- Jie J, "Regulation of apoptosis and inflammatory response in interleukin-1β-induced nucleus pulposus cells by miR-125b-5p via targeting TRIAP1", Biochem Genet, 59, pp.475~490 (2021)
- Levitskiy D, "Longitudinal stability of salivary microRNA biomarkers in children and adolescents with autism spectrum disorder", Res Autism Spectr Disord, 85, pp.101788~ (2021)
- Shen G, "MicroRNAs in the blood-brain barrier in hypoxic-ischemic brain injury", Curr Neuropharmacol, 18, pp.1180~1186 (2020)
- Wang J, "MiRNA-125a-5p attenuates blood-spinal cord barrier permeability under hypoxia in vitro", Biotechnol Lett, 42, pp.25~34 (2020)
- Yin F, "MiR-125a-3p regulates glioma apoptosis and invasion by regulating Nrg1", PLoS One, 10, pp.e0116759~ (2015)
- Nguyen LS, "Role of miR-146a in neural stem cell differentiation and neural lineage determination : relevance for neurodevelopmental disorders", Mol Autism, 9, pp.38~ (2018)
- Nguyen LS, "Profiling olfactory stem cells from living patients identifies miRNAs relevant for autism pathophysiology", Mol Autism, 7, pp.1~ (2016)
- Talebizadeh Z, "Feasibility and relevance of examining lymphoblastoid cell lines to study role of microRNAs in autism", Autism Res, 1, pp.240~250 (2008)
- Khuu C, "The three paralogous MicroRNA clusters in development and disease, miR-17-92, miR-106a-363, and miR-106b-25", Scientifica(Cairo), 2016, pp.1379643~ (2016)
- Hicks SD, "Validation of a salivary RNA test for childhood autism spectrum disorder", Front Genet, 9, pp.534~ (2018)
- Kurkewich JL, "The miR-23a~27a~24-2 microRNA cluster buffers transcription and signaling pathways during hematopoiesis", PLoS Genet, 13, pp.e1006887~ (2017)
- Zhao X, "Expression of miR-28-3p in patients with Alzheimer’s disease before and after treatment and its clinical value", Exp Ther Med, 20, pp.2218~2226 (2020)
- Hicks SD, "Saliva MicroRNA differentiates children with autism from peers with typical and atypical development", J Am Acad Child Adolesc Psychiatry, 59, pp.296~308 (2020)
- Liu H, "The inhibition of tumor protein p53 by microRNA-151a-3p induced cell proliferation, migration and invasion in nasopharyngeal carcinoma", Biosci Rep, 39, pp.BSR20191357~ (2019)
- Maness PF, "Neural recognition molecules of the immunoglobulin superfamily : signaling transducers of axon guidance and neuronal migration", Nat Neurosci, 10, pp.19~26 (2007)
- Oved K, "MicroRNA-mediated regulation of ITGB3 and CHL1 is implicated in SSRI action", Front Mol Neurosci, 10, pp.355~ (2017)
- Mundalil Vasu M, "Serum microRNA profiles in children with autism", Mol Autism, 5, pp.40~ (2014)
- Hebebrand J, "Child and adolescent psychiatric genetics", Eur Child Adolesc Psychiatry, 19, pp.259~279 (2010)
- Sarachana T, "Investigation of post-transcriptional gene regulatory networks associated with autism spectrum disorders by microRNA expression profiling of lymphoblastoid cell lines", Genome Med, 2, pp.23~ (2010)
- Yilmaz Irmak T, "Otizm davraniş kontrol listesinin(ABC)geçerlik ve güvenirliğinin incelenmesi", Çocuk Genç Ruh Sağlığı Derg, 14, pp.13~23 (2007)
- İncekaş Gassaloğlu S, "Validity and reliability analysis of Turkish version of childhood autism rating scale", Turk Psikiyatri Derg, 27, pp.266~274 (2016)
- Köse S, "The psychometric properties of Turkish version of autism spectrum screening questionnaire in children aged 6-18 years", Turk Psikiyatri Derg, 28, pp.268~277 (2017)
- Sucuoğlu B, "Sorun davranişlar kontrol listesi Türkçe formunun psikometrik özelliklerinin incelenmesi", Türk Psikol Derg, 18, pp.77~91 (2003)
- Wong ML, "Real-time PCR for mRNA quantitation", Biotechniques, 39, pp.75~85 (2005)
- Zhi F, "miR-106a-5p inhibits the proliferation and migration of astrocytoma cells and promotes apoptosis by targeting FASTK", PLoS One, 8, pp.e72390~ (2013)
- Wang H, "miR-20b", 106a modulate Ngn2 gene expression during neural differentiation of human umbilical cord mesenchymal stem cells, 2017, pp.28, 1225~1231
- Abu-Elneel K, "Heterogeneous dysregulation of microRNAs across the autism spectrum", Neurogenetics, 9, pp.153~161 (2008)
- Wright AG, "Close homolog of L1 and neuropilin 1 mediate guidance of thalamocortical axons at the ventral telencephalon", J Neurosci, 27, pp.13667~13679 (2007)
- Maass JC, "Transcriptomic analysis of mouse cochlear supporting cell maturation reveals large-scale changes in notch responsiveness prior to the onset of hearing", PLoS One, 11, pp.e0167286~ (2016)
- Zhang Y, "Circ_0005075 targeting miR-151a-3p promotes neuropathic pain in CCI rats via inducing NOTCH2 expression", Gene, 767, pp.145079~ (2021)
- Naz S, "Growth factor and receptor malfunctions associated with human genetic deafness", Clin Genet, 97, pp.138~155 (2020)
- Qiu J, "miR-125b-5p targeting TRAF6 relieves skeletal muscle atrophy induced by fasting or denervation", Ann Transl Med, 7, pp.456~ (2019)
- Levitskiy D, "Longitudinal stability of salivary microRNA biomarkers in children and adolescents with autism spectrum disorder", Res Autism Spectr Disord, 85, pp.101788~ (2021)
- Ganos C, "The pathophysiology of echopraxia", echolalia : relevance to Gilles de la Tourette syndrome, 2012, pp.27, 1222~1229
- Aloia L, "Differentiation of embryonic stem cells 1(Dies1)is a component of bone morphogenetic protein 4(BMP4)signaling pathway required for proper differentiation of mouse embryonic stem cells", J Biol Chem, 285, pp.7776~7783 (2010)
- Ziats MN, "Identification of differentially expressed microRNAs across the developing human brain", Mol Psychiatry, 19, pp.848~852 (2014)
- Pan Z, "miRNA-23a", CXCR4 regulates neuropathic pain via directly targeting TXNIP, J Neuroinflammation, pp.2018, 15[DOI]
- Atwan H, "Assessment of miR-181b-5p, miR-23a-3p, BCL-2, and IL-6 in peripheral blood mononuclear cells of autistic patients; likelihood of reliable biomarkers", Iran J Allergy Asthma Immunol, 19, pp.74~83 (2020)
- Wu YE, "Genome-wide, integrative analysis implicates microRNA dysregulation in autism spectrum disorder", Nat Neurosci, 19, pp.1463~1476 (2016)
- Sehovic E, "Identification of developmental disorders including autism spectrum disorder using salivary miRNAs in children from Bosnia and Herzegovina", PLoS One, 15, pp.e0232351~ (2020)
